PREMIER HEALTH OF AMERICA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.48 CAD | 0.00% |
|
-5.88% | +11.63% |
| Apr. 08 | Premier Health of America Inc. Announces Chief Technology Officer Changes | CI |
| Feb. 26 | Premier Health of America Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 26.97 | 58.8 | 21.89 | 19.94 | 26.65 | - | - |
| Enterprise Value (EV) 1 | 26.97 | 69.12 | 40.9 | 46.06 | 69.65 | 64.15 | 26.65 |
| P/E ratio | 700 x | 39.3 x | - | - | - | - | - |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.3 x | 0.88 x | 0.27 x | 0.22 x | 0.16 x | 0.15 x | 0.14 x |
| EV / Revenue | 1.3 x | 1.04 x | 0.51 x | 0.51 x | 0.41 x | 0.35 x | 0.14 x |
| EV / EBITDA | - | 11.7 x | 7.1 x | 5.6 x | 4.26 x | 3.61 x | 1.41 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 38,529 | 53,453 | 56,138 | 55,392 | 55,514 | - | - |
| Reference price 2 | 0.7000 | 1.100 | 0.3900 | 0.3600 | 0.4800 | 0.4800 | 0.4800 |
| Announcement Date | 12/18/20 | 12/21/21 | 12/22/22 | 12/12/23 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 20.74 | 66.63 | 80.51 | 90.39 | 170.8 | 182.6 | 186.9 |
| EBITDA 1 | - | 5.902 | 5.76 | 8.227 | 16.35 | 17.78 | 18.93 |
| EBIT | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - |
| EPS | 0.001000 | 0.0280 | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 12/18/20 | 12/21/21 | 12/22/22 | 12/12/23 | - | - | - |
1CAD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 17.63 | 18.42 | 17.58 | 22.42 | 22.09 | 21.58 | 21.8 | 23.61 | 36.97 | 43.2 |
| EBITDA 1 | 1.735 | 1.486 | 0.4668 | 1.586 | 2.222 | 1.504 | 1.936 | 2.715 | 2.622 | 3.8 |
| EBIT | - | - | - | - | - | - | - | - | 1.175 | - |
| Operating Margin | - | - | - | - | - | - | - | - | 3.18% | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | 0.203 | - |
| Net income | - | - | - | - | - | - | - | - | -0.231 | - |
| Net margin | - | - | - | - | - | - | - | - | -0.62% | - |
| EPS | - | - | - | - | - | - | - | - | -0.004000 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 12/21/21 | 2/23/22 | 5/18/22 | 8/24/22 | 12/22/22 | 2/22/23 | 5/29/23 | 8/24/23 | 2/26/24 | - |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 10.3 | 19 | 26.1 | 43 | 37.5 | - |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.749 x | 3.299 x | 3.175 x | 2.629 x | 2.109 x | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 12/18/20 | 12/21/21 | 12/22/22 | 12/12/23 | - | - | - |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.48
CAD
Average target price
1.1
CAD
Spread / Average Target
+129.17%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +11.63% | 19.47M | |
| -19.95% | 214B | |
| -9.06% | 66.6B | |
| -3.37% | 56.39B | |
| -10.49% | 46.62B | |
| +8.30% | 43.93B | |
| -6.51% | 34.19B | |
| -7.95% | 29.14B | |
| +85.24% | 24.32B | |
| +3.45% | 21.64B |
- Stock Market
- Equities
- PHA Stock
- Financials Premier Health of America Inc.
